Increasing Prevalence of Obesity, Trauma, and Liver Diseases Boosts Demand for Transcatheter Embolization and Occlusion Devices

 

Transcatheter embolization and occlusion devices are used in the therapeutic management of patients with vascular injuries caused by trauma, liver surgery, or percutaneous procedures. These devices are finding traction due to increasing prevalence of obesity and other lifestyle diseases in emerging countries of the U.S., U.K, and others. For instance, in December 2020, Medical Ingenuities received FDA 510(k) clearance for its radial artery occlusion device called PH Band.

Transcatheter embolization is an innovative, minimally-invasive procedure to reduce the size of your prostate, or simply help relieve constriction in the urethra, by expanding the existing urethral opening. Through the process, a doctor called Interventional radiologist inserts a transcatheter through a femoral artery into the male's groin. The catheter is designed for specific lengths of suctioning and is attached to a variety of stents that open various sized urethral openings. When a urethra is constricted or narrowed, the edges of the catheter will hit the sides of the opening, which pulls the catheter out and expands the opening. Once the catheter has expanded into the desired area, it is removed, the stents are removed, and the opening is closed.

Percutaneous occlusion devices are a device for the temporary relief of occlusion. It can be used in the treatment of post-operative patients, and also patients who have suffered from an aesthetic induced bleeding (princapacity) due to percutaneous translucency. The mechanism that this device works on is by filling the area affected by occlusion with a gel like material and also preventing the transport of blood from the heart to the facial areas. This gel is made up of the same material that is used for the treatment of angina, and it is known as occlusal gel. It is a very simple device, but is very effective in its functioning.

These occlusion devices are used in conjunction with cardio-resuscitation and coronary artery dilation. In addition, they help in reversing some of the more distressing effects of stroke, and they are thus used commonly in the case of patients with mild or moderate stroke, along with stoke or atrial fibrillation. Patients who are undergoing cardio-resuscitation for the treatment of a mild form of stroke may find that these treatments may be improved substantially by the application of these defibrillators.

 Patients with atrial fibrillation on the other hand, will benefit from the use of transcatheter embolization and occlusion devices, especially where they are being implanted into a chamber in which there is a possibility of reversing the ventricular tachycardia. The ventricular tachycardia leads to a massive surge of adrenaline into the cerebrospinal fluid, and this causes the ventricular tachycardia that is associated with the occurrence of aphasia and unconsciousness.